Lin Gan

Mrs. Lin Gan

Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong 510080, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Lin GanLin Gan
Lin Gan
YCYan Chen
Yan Chen
PHPeipei Hu
Peipei Hu
DWDawei Wu
Dawei Wu
YZYajuan Zhu
Yajuan Zhu
DZDingmei Zhang
Dingmei Zhang
Vaccination is a key strategy to prevent the pandemic caused by the coronavirus disease 2019 (COVID-19). This study aims to investigate the willingness of Chinese adults to be vaccinated against COVID-19 and further explore the factors that may affect their willingness. We used a self-design anonymous questionnaire to conduct an online survey via the Sojump. A total of 1009 valid questionnaires were analyzed. The age of the participants ranged from 18 to 74. Among them, 609 (60.4%, 95%CI: 57.4–63.4%) were willing to receive the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. Logistic regression analysis results showed that the age of 30–49 (OR = 2.042, 95%CI: 1.098–3.799), universities and colleges education (OR = 1.873, 95% CI = 1.016–3.451), master degree or above education (OR = 1.885, 95%CI = 1.367–2.599), previous influenza vaccination history (OR = 2.176, 95%CI: 1.474–3.211), trust in the effectiveness of the vaccine (OR = 6.419, 95%CI: 3.717–11.086), and close attention to the latest news of the vaccine (OR = 1.601, 95%CI: 1.046–2.449) were facilitative factors that affected their willingness to be vaccinated. More than half of the adults in China would be willing to receive a SARS-CoV-2 vaccine. Middle-aged people with higher education, those who had been vaccinated against influenza, and those who believed that COVID-19 vaccine was effective and paid close attention to it were more willing to be vaccinated. Our findings can provide reference for the implementation of vaccination and the prevention of COVID-19 in China. More studies are needed after the vaccine is launched.

26 September 2022 in Journal of Epidemiology and Global Health
Verified
Journal Article
Open access
PDF file
JTJinlin Tan
Jinlin Tan
ZWZhilong Wu
Zhilong Wu
Lin GanLin Gan
Lin Gan
QZQianhong Zhong
Qianhong Zhong
YZYajuan Zhu
Yajuan Zhu
DZDingmei Zhang
Dingmei Zhang
Background: During the COVID-19 pandemic, reducing the case fatality rate (CFR) becomes an urgent goal. Objective: This study explored the effect of vaccination and variants on COVID-19 fatality and provide a basis for the adjustment of control measures. Methods: This study collected epidemiological information on COVID-19 from January to October 2021. By setting different lag times, we calculated the adjusted CFR. The Spearman correlation coefficient and beta regression were used to explore factors that may affect COVID-19 fatality. Results: Every 1% increase in the percentage of full vaccinations may reduce the 3 weeks lagging CFR by 0.66%. Increasing the restrictions on internal movement from level 0 to 1, restrictions on international travel controls from level 2 to 3, and stay-at-home restrictions from level 0 to 2 were associated with an average reduction in 3 weeks lagging CFR of 0.20%, 0.39%, and 0.36%, respectively. Increasing strictness in canceling public events from level 0 to 1 and 2 may reduce the 3 weeks lagging CFR by 0.49% and 0.37, respectively. Increasing the severity of school and workplace closures from level 1 or level 0 to 3 may increase the 3 weeks lagging CFR of 0.39% and 0.83, respectively. Every 1-point increase in the Global Health Security (GHS) index score may increase the 3 weeks lagging CFR by 0.12%. Conclusion: A higher percentage of full vaccinations, higher levels of internal movement restrictions, international travel control restrictions, cancelations of public events, and stay-at-home restrictions are factors that may reduce the adjusted CFR.